Related Experiment Video

Updated: Jun 13, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Aortic stenosis and lipids: does intervention work?

Anthony S Wierzbicki1, Adie Viljoen, John B Chambers

  • 1Guy's & St Thomas' Hospitals, UK. Anthony.Wierzbicki@kcl.ac.uk

Current Opinion in Cardiology
|April 24, 2010
PubMed

Insights

Lipid-lowering therapy, specifically statins, shows limited benefit for established aortic stenosis. Further research is needed to determine their effectiveness in earlier stages of aortic valve sclerosis.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Geriatrics

Background:

  • Aortic stenosis is a prevalent condition in the elderly, significantly increasing cardiovascular risks.
  • Valve degeneration in aortic stenosis shares similarities with atherosclerosis.
  • Current treatments include surgical or endovascular interventions.

Purpose of the Study:

  • To review the potential of lipid-lowering therapy in managing aortic stenosis.
  • To evaluate the efficacy of antiatherosclerotic therapies in slowing disease progression.

Main Methods:

  • Review of retrospective studies on lipid-lowering therapy.
  • Analysis of recent clinical trials investigating aggressive statin therapy.
  • Examination of the Simvastatin-Ezetimibe and Aortic Stenosis (SEAS) trial outcomes.

Main Results:

  • Retrospective studies suggested statins might slow aortic stenosis progression.
  • Recent trials showed no benefit of aggressive statin therapy on surrogate markers.
  • The SEAS trial found no benefit for a combined endpoint but suggested potential cardiovascular event reduction.

Conclusions:

  • Statins demonstrate minimal efficacy in established, calcified aortic stenosis.
  • The role of statins in earlier stages, such as aortic valve sclerosis, requires further investigation.
Abstract

More Related Videos

A Minimally Invasive Model of Aortic Stenosis in Swine06:51

A Minimally Invasive Model of Aortic Stenosis in Swine

Published on: October 20, 2023

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...